Meeting
2022 ASCO Annual Meeting
Imaging of solid tumors using 68Ga-FAP-2286.
Authors
Thomas A. Hope
University of California, San Francisco, San Francisco, CA
Thomas A. Hope , Rahul Raj Aggarwal , Mallika Sachdev Dhawan , Robin Kate Kelley , Robert R. Flavell , Courtney Lawhn Heath , Yan Li , Sima P. Porten , Hope S. Rugo , Sue S. Yom , Robin Ippisch , Vadim S Koshkin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Molecular Diagnostics and Imaging
Clinical Trial Registration Number
NCT04621435
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 3059)
DOI
10.1200/JCO.2022.40.16_suppl.3059
Abstract #
3059
Poster Bd #
51
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
68Ga-FAPI-46 PET for cancer imaging: A prospective single-arm clinical trial.
First Author: Wolfgang P. Fendler
Poster
2021 ASCO Annual Meeting
Validation of FAPi PET biodistribution by immunohistochemistry in patients with solid cancers: A prospective exploratory study.
First Author: Christine Mona
Poster
2019 ASCO Annual Meeting
Image-guided surgery for tumor agnostic detection of solid tumors using the pH-activated micellar imaging agent ONM-100.
First Author: Floris Jan Voskuil
Poster
2018 ASCO Annual Meeting
18F-Fluoroestradiol (FES) and 18F-Fluorodeoxyglucose (FDG) PET imaging in lobular breast cancer.
First Author: Poorni Manohar